Test Price
600 AEDโ Home Collection Available
Quadruple Marker Test in UAE | 600 AED | PDPL Compliant Prenatal Screening
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy. Available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Quadruple Marker Test (Quad Screen) is a second-trimester maternal serum screening test that quantifies four key biochemical markers: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. It helps assess the risk of fetal chromosomal conditions such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and neural tube defects.
| Feature | Our Quadruple Marker Test | Closest Alternative (1st Trimester Combined) |
|---|---|---|
| Markers Measured | 4 (AFP, hCG, uE3, Inhibin A) | 2 (PAPP-A, free ฮฒ-hCG) + NT ultrasound |
| Detection Rate (T21) | ~80% | ~85% when combined with NT |
| Methodology | Chemiluminescent Immunoassay (CLIA) | CLIA / Ultrasound |
| Turnaround Time | 3โ4 Days | 3โ5 Days (combined) |
| Price | 600 AED | Varies, often higher with ultrasound |
Physician Insight & Safety Protocols
โDear patient, the Quadruple Marker test provides a statistical risk assessment, not a definitive diagnosis. A โscreen-positiveโ result simply indicates that further diagnostic testing, such as amniocentesis or high-resolution ultrasound, is recommended. Rest assured, my team and I are here to guide you through every step of the process, translating complex results into a clear clinical pathway.โ
โ Dr. Ajay Singh, General Practitioner | DHA: 36234132
Safety Exclusion Criteria & Emergency Red Flags
- Not suitable in some cases of multiple gestation or vanishing twin (confirm with physician).
- Caution in insulin-dependent diabetes; may affect marker levels.
- Seek immediate emergency care if you experience: severe abdominal pain, heavy vaginal bleeding, sudden swelling, severe headache, or visual disturbances. These may indicate unrelated pregnancy complications.
Patient FAQ & Clinical Guidance
1. What is the Quadruple Marker test and why is it done?
Snippet: The Quadruple Marker test measures four pregnancy hormones to screen for chromosomal and neural tube defects. This test assesses the risk of Down syndrome, Trisomy 18, and open neural tube defects in the second trimester. It empowers expectant parents to make informed healthcare decisions.
2. How accurate is the Quadruple Marker test and what do results mean?
Snippet: The Quadruple Marker detects up to 80% of chromosomal anomalies with a 5% false-positive rate. A screen-positive result indicates increased risk, prompting further diagnostic steps like amniocentesis. A screen-negative lowers the probability but does not eliminate it entirely.
3. When should the Quadruple Marker test be taken during pregnancy?
Snippet: The Quadruple Marker is ideally conducted at 15โ20 weeks of pregnancy for reliable screening. Optimal timing ensures accurate marker levels for risk calculation. Testing outside this window may reduce clinical reliability and recommendation.
UAE Regulatory & Data Privacy Adherence
Your data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Quadruple Marker Test (Quad Screen) |
| Price (AED) | 600 AED |
| Turnaround Time | 3โ4 Days |
| Sample Type / Matrix | Maternal Serum (Peripheral Venipuncture) |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) |
| ICD-10-CM Code | Z36.0, O28.5 |
| LOINC Code | 49586-2 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians